NO20043698L - Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid - Google Patents

Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid

Info

Publication number
NO20043698L
NO20043698L NO20043698A NO20043698A NO20043698L NO 20043698 L NO20043698 L NO 20043698L NO 20043698 A NO20043698 A NO 20043698A NO 20043698 A NO20043698 A NO 20043698A NO 20043698 L NO20043698 L NO 20043698L
Authority
NO
Norway
Prior art keywords
age
organs
heart failure
sodium hydrogen
ace inhibitors
Prior art date
Application number
NO20043698A
Other languages
English (en)
Norwegian (no)
Inventor
Wolfgang Linz
Ursula Schindler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20043698L publication Critical patent/NO20043698L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20043698A 2002-02-04 2004-08-31 Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid NO20043698L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204571 2002-02-04
PCT/EP2003/000587 WO2003066045A1 (de) 2002-02-04 2003-01-22 Kombinationspräparat des natrium-wasserstoff-austauch-inhibitors cariporide mit ace-hemmern zur verhinderung der herzinsuffizienz und anderer altersbedingter organ-dysfunktionen, altersbedingter erkrankungen und zur lebensverlängerung

Publications (1)

Publication Number Publication Date
NO20043698L true NO20043698L (no) 2004-08-31

Family

ID=27674558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043698A NO20043698L (no) 2002-02-04 2004-08-31 Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid

Country Status (23)

Country Link
EP (1) EP1474134B1 (sr)
JP (1) JP4733348B2 (sr)
KR (1) KR20040083498A (sr)
CN (1) CN1319528C (sr)
AR (1) AR038387A1 (sr)
AT (1) ATE520398T1 (sr)
AU (1) AU2003244430A1 (sr)
BR (1) BR0307443A (sr)
CA (1) CA2474888A1 (sr)
CO (1) CO5601009A2 (sr)
HR (1) HRP20040702A2 (sr)
HU (1) HUP0402593A2 (sr)
MA (1) MA27170A1 (sr)
MX (1) MXPA04007569A (sr)
NO (1) NO20043698L (sr)
NZ (1) NZ534479A (sr)
PE (1) PE20040188A1 (sr)
PL (1) PL370488A1 (sr)
RS (1) RS68204A (sr)
RU (1) RU2004126702A (sr)
TW (1) TW200306850A (sr)
WO (1) WO2003066045A1 (sr)
ZA (1) ZA200406066B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2552331B1 (en) * 2010-03-31 2020-01-08 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855392A3 (de) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (de) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung

Also Published As

Publication number Publication date
BR0307443A (pt) 2005-01-04
MA27170A1 (fr) 2005-01-03
CN1694697A (zh) 2005-11-09
RU2004126702A (ru) 2005-04-20
JP2005519072A (ja) 2005-06-30
EP1474134A1 (de) 2004-11-10
AU2003244430A1 (en) 2003-09-02
ZA200406066B (en) 2005-06-08
EP1474134B1 (de) 2011-08-17
HUP0402593A2 (hu) 2005-04-28
MXPA04007569A (es) 2004-11-01
KR20040083498A (ko) 2004-10-02
JP4733348B2 (ja) 2011-07-27
CA2474888A1 (en) 2003-08-14
PL370488A1 (en) 2005-05-30
NZ534479A (en) 2006-03-31
WO2003066045A1 (de) 2003-08-14
AR038387A1 (es) 2005-01-12
CO5601009A2 (es) 2006-01-31
RS68204A (sr) 2007-02-05
ATE520398T1 (de) 2011-09-15
CN1319528C (zh) 2007-06-06
PE20040188A1 (es) 2004-05-17
HRP20040702A2 (en) 2005-04-30
TW200306850A (en) 2003-12-01

Similar Documents

Publication Publication Date Title
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
MXJL06000006A (es) Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
NO20070247L (no) Amino-5,5-difenylimidazolonderivater for inhibisjon av beta-sekretase
IS7678A (is) Samsetning IBAT tálma og málmsalts til að meðhöndla niðurgang
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
NO20044763L (no) 1-(aminoalkyl)-3-sulfonylazaindoler som 5-hydroksytryptamin-6 ligander
DK1753748T3 (da) Prolinderivater og deres anvendelse som dipeptidyl-peptidase-IV-inhibitorer
DK1956004T3 (da) Quinolinderivater og deres anvendelse som 5-HT6-ligander
EA200700058A1 (ru) Соединения, композиции и способы их использования
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
WO2004037796A3 (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
DK1973540T3 (da) Anvendelse af benzokondenserede heterocycliske sulfamidderivater til behandling af smerte
ECSP055844A (es) Nuevos compuestos triciclicos
DK1505871T3 (da) Konservering af rna og morfologi i celler og væv
SE0201940D0 (sv) New combination II
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
NO20080781L (no) GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
NO20043698L (no) Kombinasjonspreparat av natrium-hydrogenbytteinhibitoren cariporid med ACE-inhibitorer for prevensjon av hjertesvikt og andre aldersrelaterte dysfunksjoner i organer, aldersrelaterte sykdommer og for forlenget levetid
NO20013145L (no) Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden
ATE306267T1 (de) Kombinationsbehandlung bei akutem myokardinfarkt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application